149 related articles for article (PubMed ID: 21744149)
1. [Erratum to: Tyrosin kinase inhibitors in oncology.].
Zander T; Hallek M
Internist (Berl); 2011 Jul; ():. PubMed ID: 21744149
[No Abstract] [Full Text] [Related]
2. [Tyrosine kinase inhibitors in oncology].
Zander T; Hallek M
Internist (Berl); 2011 May; 52(5):595-600. PubMed ID: 21503656
[TBL] [Abstract][Full Text] [Related]
3. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization.
Chaoran Z; Zhirong L; Gezhi X
Graefes Arch Clin Exp Ophthalmol; 2011 Oct; 249(10):1493-501. PubMed ID: 21574021
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Oxidative Stress in Resistance to Tyrosine-Kinase Inhibitors Therapy in Chronic Myeloid Leukemia.
Pascu VÎnturiŞ EG; GĂman AM
Curr Health Sci J; 2020; 46(4):420-432. PubMed ID: 33717518
[TBL] [Abstract][Full Text] [Related]
5. Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function.
Damele L; Montaldo E; Moretta L; Vitale C; Mingari MC
Front Immunol; 2018; 9():2433. PubMed ID: 30405627
[TBL] [Abstract][Full Text] [Related]
6. [Dasatinib. A novel tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia].
Bjerrum OW; Dufva IH; Stentoft J; Hasselbalch HC
Ugeskr Laeger; 2008 Jan; 170(5):331-3. PubMed ID: 18252160
[TBL] [Abstract][Full Text] [Related]
7. Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer.
Carmi C; Mor M; Petronini PG; Alfieri RR
Biochem Pharmacol; 2012 Dec; 84(11):1388-99. PubMed ID: 22885287
[TBL] [Abstract][Full Text] [Related]
8. Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology.
Neradil J; Kyr M; Polaskova K; Kren L; Macigova P; Skoda J; Sterba J; Veselska R
Front Oncol; 2019; 9():930. PubMed ID: 31616636
[TBL] [Abstract][Full Text] [Related]
9. [Targeted therapeutics and their role in the treatment of internal diseases].
Klener P
Vnitr Lek; 2013 Jan; 59(1):5-12. PubMed ID: 23427997
[TBL] [Abstract][Full Text] [Related]
10. Incidence of cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors.
Casavecchia G; Spinosa G; De Gennaro L; Zicchino S; Gravina M; Magnesa M; Di Biase M; Brunetti ND
Acta Cardiol; 2022 Apr; 77(2):130-135. PubMed ID: 33685352
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors and drug interactions: a review with practical recommendations.
Pajares B; Torres E; Trigo JM; Sáez MI; Ribelles N; Jiménez B; Alba E
Clin Transl Oncol; 2012 Feb; 14(2):94-101. PubMed ID: 22301397
[TBL] [Abstract][Full Text] [Related]
12. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors.
Naito Y; Mishima S; Akagi K; Hayashi N; Hirasawa A; Hishiki T; Igarashi A; Ikeda M; Kadowaki S; Kajiyama H; Kato M; Kenmotsu H; Kodera Y; Komine K; Koyama T; Maeda O; Miyachi M; Nishihara H; Nishiyama H; Ohga S; Okamoto W; Oki E; Ono S; Sanada M; Sekine I; Takano T; Tao K; Terashima K; Tsuchihara K; Yatabe Y; Yoshino T; Baba E
Int J Clin Oncol; 2023 Jul; 28(7):827-840. PubMed ID: 37212982
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.
Verlohren S; Perschel FH; Thilaganathan B; Dröge LA; Henrich W; Busjahn A; Khalil A
Hypertension; 2017 Jun; 69(6):1192-1197. PubMed ID: 28461601
[TBL] [Abstract][Full Text] [Related]
14. [The content of pepsinogen in the blood plasma of growing fallow deer (Dama dama L.) raised helminth free and under natural conditions in captivity].
Rehbein S; Bienioschek S; Sachse M
Berl Munch Tierarztl Wochenschr; 1995 Sep; 108(9):321-5. PubMed ID: 7495412
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of (
Marek L; Kolman L; Váňa J; Svoboda J; Hanusek J
Beilstein J Org Chem; 2021; 17():527-539. PubMed ID: 33727976
[TBL] [Abstract][Full Text] [Related]
16. Current Treatment Options for Chronic Myeloid Leukemia Patients Failing Second-Generation Tyrosine Kinase Inhibitors.
García-Gutiérrez V; Hernández-Boluda JCC
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32679880
[TBL] [Abstract][Full Text] [Related]
17. Recent clinical findings on the role of kinase inhibitors in COVID-19 management.
Malekinejad Z; Baghbanzadeh A; Nakhlband A; Baradaran B; Jafari S; Bagheri Y; Raei F; Montazersaheb S; Farahzadi R
Life Sci; 2022 Oct; 306():120809. PubMed ID: 35841979
[TBL] [Abstract][Full Text] [Related]
18. [Gastrointestinal stromal tumor--analysis of a patient group, literature overview].
Pohnán R; Ryska M; Dolezel R; Veverová I; Linke Z
Rozhl Chir; 2009 Nov; 88(11):629-33. PubMed ID: 20662443
[TBL] [Abstract][Full Text] [Related]
19. Real world treatment sequences and outcomes for metastatic renal cell carcinoma.
Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Lin CY; Hung SC; Chiu KY; Yang SF
PLoS One; 2023; 18(11):e0294039. PubMed ID: 37992086
[TBL] [Abstract][Full Text] [Related]
20. Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib.
Mohammad H; Madsen K; Graumann O; Loya AC; Jensen NV; Dahlrot RH
Urol Case Rep; 2022 Jan; 40():101880. PubMed ID: 34692420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
